SCHEMBL183916

SCHEMBL183916

CCCCCCCCCCCCC(O)COc1ccc([I+]c2ccccc2)cc1.CCCCCCCCCCCCC(O)COc1ccc([I+]c2ccccc2)cc1.CCCCCCCCCCCCC(O)COc1ccc([I+]c2ccccc2)cc1.CCCCCCCCCCCCC(O)COc1ccc([I+]c2ccccc2)cc1.CCCCCCCCCCCCC(O)COc1ccc([I+]c2ccccc2)cc1.CCCCCCCCCCCCC(O)COc1ccc([I+]c2ccccc2)cc1.CCCCCCCCCCCCC(O)COc1ccc([I+]c2ccccc2)cc1.CCCCCCCCCCCCC(O)COc1ccc([I+]c2ccccc2)cc1.CCCCCCCCCCCCC(O)COc1ccc([I+]c2ccccc2)cc1.CCCCCCCCCCCCC(O)COc1ccc([I+]c2ccccc2)cc1.CCCCCCCCCCCCC(O)COc1ccc([I+]c2ccccc2)cc1.CCCCCCCCCCCCC(O)COc1ccc([I+]c2ccccc2)cc1.O=[Sb]([O-])([O-])F.O=[Sb]([O-])([O-])F.O=[Sb]([O-])([O-])F.O=[Sb]([O-])([O-])F.O=[Sb]([O-])([O-])F.O=[Sb]([O-])([O-])F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G4B P0C869 2/20 0.46
S1PR1 P21453 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
CTRC Q99895 1/20 0.39
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA9 Q16790 2/20 0.38
MAPT P10636 2/20 0.38
HTT P42858 2/20 0.38
CA4 P22748 1/20 0.38
CA7 P43166 1/20 0.38
TBXA2R P21731 1/20 0.38
PTGER1 P34995 1/20 0.38
PTGFR P43088 1/20 0.38
PTGER3 P43115 1/20 0.38
PTGDR Q13258 1/20 0.38
ABCB1 P08183 1/20 0.37
LMNA P02545 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL63676 0.92 PLA2G4B (0.50) PLA2G4BS1PR1SMN1; SMN2NPC1RAB9A
SCHEMBL4455826 0.92 PLA2G4B (0.50) PLA2G4BS1PR1SMN1; SMN2NPC1RAB9A
SCHEMBL28789833 0.91 PLA2G4B (0.43) PLA2G4BS1PR1SMN1; SMN2NPC1RAB9A
Hydrochloric Acid SCHEMBL31093484 0.91 PLA2G4B (0.49) PLA2G4BS1PR1SMN1; SMN2NPC1RAB9A
SCHEMBL4852949 0.90 PLA2G4B (0.39) PLA2G4BS1PR1SMN1; SMN2TBXA2RPTGER1
SCHEMBL29396017 0.90 PLA2G4B (0.46) PLA2G4BS1PR1SMN1; SMN2NPC1RAB9A
SCHEMBL29465911 0.90 PLA2G4B (0.46) PLA2G4BS1PR1SMN1; SMN2NPC1RAB9A
Trifluoromethanesulfonic Acid SCHEMBL1042658 0.88 PLA2G4B (0.44) PLA2G4BS1PR1SMN1; SMN2NPC1RAB9A
SCHEMBL3099626 0.88 PLA2G4B (0.44) PLA2G4BS1PR1SMN1; SMN2NPC1RAB9A
SCHEMBL225850 0.85 PLA2G4B (0.44) PLA2G4BS1PR1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1673663-B1 LIGHT SENSITIVE COATING COMPOSITIONS FOR LITHOGRAPHIC ELEMENTS IBF IND BRASILEIRA DE FILMES SA (BR) 2011-03-23 EP claimed
EP-2872546-B1 CROSSLINKABLE SILOXANES BY ACID-CATALYZED POLYMERIZATION OF OXASILACYCLENES WACKER CHEMIE AG (DE) 2016-06-22 EP disclosed
US-20150175749-A1 CROSSLINKABLE SILOXANES BY ACID-CATALYZED POLYMERIZATION OF OXASILACYCLES WACKER CHEMIE AG (DE) 2015-06-25 US disclosed
EP-2255401-B1 NONWOVEN FABRIC HAVING CROSS-LINKING MATERIAL FREUDENBERG CARL KG (DE) 2015-04-01 EP disclosed
EP-1671379-B2 ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR, AN ORGANIC SEMICONDUCTOR, AND AN INTERMEDIATE BUFFER LAYER MADE OF A POLYMER THAT IS CATIONICALLY POLYMERIZABLE MERCK PATENT GMBH (DE) 2014-10-01 EP disclosed
WO-2013156317-A1 METHOD FOR PRODUCING CROSS-LINKABLE POLYOLEFIN COPOLYMERS WACKER CHEMIE AG (DE) 2013-10-24 WO disclosed
EP-2310441-B1 METHOD FOR THE PRODUCTION OF FOAMS ON SILICON BASIS WACKER CHEMIE AG (DE) 2013-03-13 EP disclosed
EP-2245034-B1 CURABLE POLYMER MIXTURES WACKER CHEMIE AG (DE) 2012-01-04 EP disclosed
EP-1671379-B8 ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR, AN ORGANIC SEMICONDUCTOR, AND AN INTERMEDIATE BUFFER LAYER MADE OF A POLYMER THAT IS CATIONICALLY POLYMERIZABLE MERCK PATENT GMBH (DE) 2011-03-23 EP disclosed
EP-1671379-B1 ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR, AN ORGANIC SEMICONDUCTOR, AND AN INTERMEDIATE BUFFER LAYER MADE OF A POLYMER THAT IS CATIONICALLY POLYMERIZABLE MERCK PATENT GMBH (DE) 2010-12-22 EP disclosed
EP-1661191-B1 ELECTRONIC DEVICES COMPRISING AN ORGANIC CONDUCTOR AND SEMICONDUCTOR AS WELL AS AN INTERMEDIATE BUFFER LAYER MADE OF A CROSSLINKED POLYMER MERCK PATENT GMBH (DE) 2008-12-17 EP disclosed
EP-1984964-A1 ELECTRONIC COMPONENT, METHOD FOR ITS PRODUCTION AND ITS USE Merck Patent GmbH (DE) 2008-10-29 EP disclosed
EP-1719193-B1 METHOD FOR CROSS-LINKING AN ORGANIC SEMI-CONDUCTOR MERCK PATENT GMBH (DE) 2008-04-16 EP disclosed
WO-2007093282-A1 ELECTRONIC COMPONENT, METHOD FOR ITS PRODUCTION AND ITS USE MERCK PATENT GMBH (DE) 2007-08-23 WO disclosed
EP-1719193-A2 METHOD FOR CROSS-LINKING AN ORGANIC SEMI-CONDUCTOR Merck Patent GmbH (DE) 2006-11-08 EP disclosed
EP-1671379-A1 ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR, AN ORGANIC SEMICONDUCTOR, AND AN INTERMEDIATE BUFFER LAYER MADE OF A POLYMER THAT IS CATIONICALLY POLYMERIZABLE AND CONTAINS NO PHOTOACID MERCK PATENT GmbH (DE) 2006-06-21 EP disclosed
EP-1661191-A1 ELECTRONIC DEVICES COMPRISING AN ORGANIC CONDUCTOR AND SEMICONDUCTOR AS WELL AS AN INTERMEDIATE BUFFER LAYER MADE OF A CROSSLINKED POLYMER Merck Patent GmbH (DE) 2006-05-31 EP disclosed
WO-2005083812-A2 METHOD FOR CROSS-LINKING AN ORGANIC SEMI-CONDUCTOR MERCK PATENT GMBH (DE) 2005-09-09 WO disclosed
WO-2005024971-A1 ELECTRONIC DEVICES COMPRISING AN ORGANIC CONDUCTOR AND SEMICONDUCTOR AS WELL AS AN INTERMEDIATE BUFFER LAYER MADE OF A CROSSLINKED POLYMER MERCK PATENT GMBH (DE) 2005-03-17 WO disclosed
WO-2005024970-A1 ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR, AN ORGANIC SEMICONDUCTOR, AND AN INTERMEDIATE BUFFER LAYER MADE OF A POLYMER THAT IS CATIONICALLY POLYMERIZABLE AND CONTAINS NO PHOTOACID COVION ORGANIC SEMICONDUCTORS GMBH (DE) 2005-03-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175749-A1 CROSSLINKABLE SILOXANES BY ACID-CATALYZED POLYMERIZATION OF OXASILACYCLES MCM4, ITGB4, ITGA4 PLA2G4B 3274/4885S1PR1 2701/4885SMN1; SMN2 1131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.